- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-18-18-12-12-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 2 residues within 4Å:- Chain A: N.67, F.90
Ligand excluded by PLIPNAG.3: 4 residues within 4Å:- Chain C: N.67, F.90
- Chain I: Q.65, D.66
Ligand excluded by PLIPNAG.4: 5 residues within 4Å:- Chain E: N.67, M.118
- Chain G: Y.60, Q.65, D.66
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain K: N.67, F.90
Ligand excluded by PLIPNAG.7: 4 residues within 4Å:- Chain M: N.67, F.90
- Chain S: Q.65, D.66
Ligand excluded by PLIPNAG.8: 5 residues within 4Å:- Chain O: N.67, M.118
- Chain Q: Y.60, Q.65, D.66
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain U: N.67, F.90
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain 2: Q.65, D.66
- Chain W: N.67, F.90
Ligand excluded by PLIPNAG.12: 5 residues within 4Å:- Chain 0: Y.60, Q.65, D.66
- Chain Y: N.67, M.118
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain 4: N.67, F.90
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain 6: N.67, F.90
- Chain c: Q.65, D.66
Ligand excluded by PLIPNAG.16: 5 residues within 4Å:- Chain 8: N.67, M.118
- Chain a: Y.60, Q.65, D.66
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain e: N.67, F.90
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain g: N.67, F.90
- Chain m: Q.65, D.66
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain i: N.67, M.118
- Chain k: Y.60, Q.65, D.66
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain o: N.67, F.90
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain q: N.67, F.90
- Chain w: Q.65, D.66
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain s: N.67, M.118
- Chain u: Y.60, Q.65, D.66
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lim, X.X. et al., Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics. Cell (2021)
- Release Date
- 2021-12-29
- Peptides
- Envelope protein E: ACEKMOUWY468egioqs
Small envelope protein M: BDFLNPVXZ579fhjprt
Fab_C10_light_chain: GIQS02ackmuw
Fab_C10_heavy_chain: HJRT13bdlnvx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
AE
CK
BM
AO
CU
BW
AY
C4
B6
A8
Ce
Bg
Ai
Co
Bq
As
CB
ED
DF
FL
EN
DP
FV
EX
DZ
F5
E7
D9
Ff
Eh
Dj
Fp
Er
Dt
FG
II
GQ
IS
G0
I2
Ga
Ic
Gk
Im
Gu
Iw
GH
MJ
HR
MT
H1
M3
Hb
Md
Hl
Mn
Hv
Mx
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-18-18-12-12-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lim, X.X. et al., Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics. Cell (2021)
- Release Date
- 2021-12-29
- Peptides
- Envelope protein E: ACEKMOUWY468egioqs
Small envelope protein M: BDFLNPVXZ579fhjprt
Fab_C10_light_chain: GIQS02ackmuw
Fab_C10_heavy_chain: HJRT13bdlnvx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
AE
CK
BM
AO
CU
BW
AY
C4
B6
A8
Ce
Bg
Ai
Co
Bq
As
CB
ED
DF
FL
EN
DP
FV
EX
DZ
F5
E7
D9
Ff
Eh
Dj
Fp
Er
Dt
FG
II
GQ
IS
G0
I2
Ga
Ic
Gk
Im
Gu
Iw
GH
MJ
HR
MT
H1
M3
Hb
Md
Hl
Mn
Hv
Mx
H